We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-2.04%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$17.4B
AUM Growth
-$2.18B
(-11%)
Cap. Flow
-$1.39B
Cap. Flow
% of AUM
-7.99%
Top 10 Holdings %
Top 10 Hldgs %
37.61%
Holding
560
New
49
Increased
117
Reduced
231
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$275M |
| 2 |
Pinterest
PINS
|
+$127M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$119M |
| 4 |
Humana
HUM
|
+$61.6M |
| 5 |
Adobe
ADBE
|
+$58.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Las Vegas Sands
LVS
|
+$135M |
| 2 |
JPMorgan Chase
JPM
|
+$122M |
| 3 |
Mercado Libre
MELI
|
+$115M |
| 4 |
TransDigm Group
TDG
|
+$101M |
| 5 |
GE HealthCare
GEHC
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.55% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Communication Services | 10.39% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Arrowhead Research
ARWR
$12.3B
| $1.25M | 0.01% |
46,419
-120,636
| -72% | -$3.7M |
|
352
Forte Biosciences
FBRX
$1.58B
| $1.22M | 0.01% |
+73,559
| New | +$1.63M |
|
353
CAVA Group
CAVA
$7.74B
| $1.17M | 0.01% |
38,302
+27,405
| +251% | +$1.2M |
|
354
Newmont
NEM
$101B
| $1.15M | 0.01% |
31,158
| – | – |
|
355
GSK
GSK
$104B
| $1.15M | 0.01% |
31,591
| – | – |
|
356
MaxCyte
MXCT
$112M
| $1.13M | 0.01% |
360,874
-94
| -0% | -$378 |
|
357
Carlyle Group
CG
$16.3B
| $1.11M | 0.01% |
36,696
| – | – |
|
358
Dow Inc
DOW
$21.7B
| $1.09M | 0.01% |
21,158
| – | – |
|
359
MP Materials
MP
$7.42B
| $1.04M | 0.01% |
54,382
-11,590
| -18% | -$257K |
|
360
Oscar Health
OSCR
$9.42B
| $934K | 0.01% |
167,632
+14,699
| +10% | +$103K |
|
361
Charter Communications
CHTR
$16.9B
| $921K | 0.01% |
+2,095
| New | +$871K |
|
362
Kenvue
KVUE
$37.1B
| $908K | 0.01% |
45,220
+42,899
| +1,848% | +$993K |
|
363
New Oriental
EDU
$9B
| $773K | ﹤0.01% |
13,200
-1,300
| -9% | -$68.2K |
|
364
Pinduoduo
PDD
$124B
| $736K | ﹤0.01% |
7,500
+3,013
| +67% | +$260K |
|
365
Doximity
DOCS
$3.82B
| $727K | ﹤0.01% |
34,272
-7
| -0% | -$191 |
|
366
American Express
AXP
$228B
| $686K | ﹤0.01% |
4,600
-106
| -2% | -$17.3K |
|
367
Burlington
BURL
$23.4B
| $682K | ﹤0.01% |
+5,041
| New | +$809K |
|
368
Autodesk
ADSK
$49.6B
| $659K | ﹤0.01% |
3,184
| – | – |
|
369
Align Technology
ALGN
$12.4B
| $623K | ﹤0.01% |
2,041
+1,933
| +1,790% | +$668K |
|
370
Ionis Pharmaceuticals
IONS
$8.85B
| $615K | ﹤0.01% |
+13,566
| New | +$560K |
|
371
Accenture
ACN
$99.9B
| $600K | ﹤0.01% |
1,953
-454
| -19% | -$143K |
|
|
DADA
372
DELISTED
Dada Nexus
DADA
| $574K | ﹤0.01% |
129,000
+19,000
| +17% | +$101K |
|
373
Aptiv
APTV
$12.3B
| $560K | ﹤0.01% |
5,682
| – | – |
|
374
Super Micro Computer
SMCI
$17.9B
| $553K | ﹤0.01% |
20,170
+4,420
| +28% | +$123K |
|
375
Stevanato
STVN
$5.51B
| $553K | ﹤0.01% |
18,604
-62,925
| -77% | -$1.97M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2023 Portfolio in Review
As of Q3 2023, Fred Alger Management held 560 positions worth $17.4B, down 11% from $19.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Fred Alger Management withdrew a net $1.39B in Q3 2023, closing 99 positions and reducing 231 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $41.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Extreme Networks worth $33.9M.
- Fred Alger Management's largest Q3 2023 buy was Extreme Networks: 1,401,093 shares worth $33.9M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q3 2023, an estimated $275M increase.
- Fred Alger Management's biggest Q3 2023 reduction was Las Vegas Sands, cutting an estimated $135M.
- Fred Alger Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $41.5M.
- Fred Alger Management's ten largest holdings make up 38% of its $17.4B portfolio in Q3 2023.
- Fred Alger Management opened 49 new positions and closed 99 in Q3 2023.
- Fred Alger Management's portfolio value fell 11% quarter-over-quarter to $17.4B.
Based on Fred Alger Management's 13F filing for Q3 2023, filed 14 Nov 2023.